A combination treatment involving tobevibart and elebsiran significantly improved disease activity in adults with chronic ...

This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the seventh installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

This story is part of a larger series on viroids and virusoids, small infectious RNAs. It is also the eighth installment in a series on hepatitis D virus, a virusoid-like pathogen that causes serious ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus (HDV) infection, according to the phase II SOLSTICE trial. ECLIPSE MedPage ...

LA Times Studios produces content by working closely with scientists and healthcare experts as well as sourcing scholarly-reviewed medical and science journals and is independent of the L.A. Times ...

• The remaining genotypes are present in Africa. Patients with repeated exposure to HDV can have more than 1 circulating genotype. As a defective RNA virus requiring concurrent HBV infection to ...

Hepatitis B is a life-threatening liver infection that is caused by the hepatitis B virus, whereas, hepatitis D infection only occurs in people who are infected with the hepatitis B virus. It ...

WASHINGTON -- Hepatitis D may be the loneliest hepatitis virus around, but it's still here and needs attention, several speakers said here at the Digestive Disease Week meeting. "Even though it's been ...

The WHO has classified Hepatitis D virus (HDV) as carcinogenic, linking it to liver cancer alongside Hepatitis B and C. HDV, requiring HBV to infect, worsens liver damage, especially in co-infected ...

Dublin, Sept. 09, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis D Market - A Global and Regional Analysis: Focus on Treatment Type, Diagnostic Method, and Region - Analysis and Forecast, 2025-2035" report ...